These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 31665371)
1. Denosumab Therapy Obscures Histological Features of Giant Cell Tumor of Bone. Gilani A; Kleinschmidt-DeMasters BK J Neuropathol Exp Neurol; 2019 Dec; 78(12):1171-1173. PubMed ID: 31665371 [TBL] [Abstract][Full Text] [Related]
2. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone. Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220 [TBL] [Abstract][Full Text] [Related]
3. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature. Al Farii H; McChesney G; Patel SS; Rhines LD; Lewis VO; Bird JE Spine J; 2024 Jun; 24(6):1056-1064. PubMed ID: 38301904 [TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases. Deveci MA; Paydaş S; Gönlüşen G; Özkan C; Biçer ÖS; Tekin M Acta Orthop Traumatol Turc; 2017 Jan; 51(1):1-6. PubMed ID: 27784623 [TBL] [Abstract][Full Text] [Related]
5. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience. Agarwal MG; Gundavda MK; Gupta R; Reddy R Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215 [TBL] [Abstract][Full Text] [Related]
6. Histopathological response to denosumab in giant cell tumours of bone - A review of 11 cases. Kumar R; Mallya V; Mandal S; Tomar R; Khurana N; Maini L J Cancer Res Ther; 2023; 19(3):768-772. PubMed ID: 37470608 [TBL] [Abstract][Full Text] [Related]
7. Giant Cell Lesions of the Maxillofacial Skeleton Express RANKL by RNA In Situ Hybridization Regardless of Histologic Pattern. Stagner AM; Sajed DP; Nielsen GP; Ebb DH; Faquin WC; Chebib I; Rivera MN; Ting DT; Resnick CM; Peacock ZS; Kaban LB; Deshpande V Am J Surg Pathol; 2019 Jun; 43(6):819-826. PubMed ID: 30998511 [TBL] [Abstract][Full Text] [Related]
8. Malignant Transformation of a Giant Cell Tumor of Bone Treated with Denosumab: A Case Report. Park A; Cipriano CA; Hill K; Kyriakos M; McDonald DJ JBJS Case Connect; 2016; 6(3):e78. PubMed ID: 29252655 [TBL] [Abstract][Full Text] [Related]
9. Spectrum of histological features of Denosumab treated Giant Cell Tumor of Bone; potential pitfalls and diagnostic challenges for pathologists. Tariq MU; Umer M; Khan Z; Saeed J; Siddiqui MA; Din NU Ann Diagn Pathol; 2020 Apr; 45():151479. PubMed ID: 32088577 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India. Rekhi B; Verma V; Gulia A; Jambhekar NA; Desai S; Juvekar SL; Bajpai J; Puri A Pathol Oncol Res; 2017 Jan; 23(1):157-164. PubMed ID: 27722984 [TBL] [Abstract][Full Text] [Related]
11. Morphologic evaluation of the effect of denosumab on giant cell tumors of bone and a new grading scheme. Erdogan KE; DevecI MA; Paydas S; Gonlusen G Pol J Pathol; 2016; 67(4):392-397. PubMed ID: 28547968 [TBL] [Abstract][Full Text] [Related]
12. Denosumab-treated giant cell tumor of bone. Its histologic spectrum and potential diagnostic pitfalls. Roitman PD; Jauk F; Farfalli GL; Albergo JI; Aponte-Tinao LA Hum Pathol; 2017 May; 63():89-97. PubMed ID: 28235628 [TBL] [Abstract][Full Text] [Related]
13. Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy. Matcuk GR; Patel DB; Schein AJ; White EA; Menendez LR Skeletal Radiol; 2015 Jul; 44(7):1027-31. PubMed ID: 25712768 [TBL] [Abstract][Full Text] [Related]
14. A High-grade Sarcoma Arising in a Patient With Recurrent Benign Giant Cell Tumor of the Proximal Tibia While Receiving Treatment With Denosumab. Aponte-Tinao LA; Piuzzi NS; Roitman P; Farfalli GL Clin Orthop Relat Res; 2015 Sep; 473(9):3050-5. PubMed ID: 25758379 [TBL] [Abstract][Full Text] [Related]
15. Histopathological Features Of Denosumab Treated Giant Cell Tumours Of Bone "A Single Institutional Experience" At A Tertiary Care Center, Karachi. Ali SM; Yaqoob N; Aftab Aslam K; Tauseef S; Ahmed SK; Jilani SAA; Jamal S J Ayub Med Coll Abbottabad; 2022; 34(1):73-81. PubMed ID: 35466631 [TBL] [Abstract][Full Text] [Related]
16. How safe and effective is denosumab for bone giant cell tumour? Errani C; Tsukamoto S; Mavrogenis AF Int Orthop; 2017 Nov; 41(11):2397-2400. PubMed ID: 28646421 [TBL] [Abstract][Full Text] [Related]
17. Treatment of a skull-base giant cell tumor with endoscopic endonasal resection and denosumab: case report. Goto Y; Furuno Y; Kawabe T; Ohwada K; Tatsuzawa K; Sasajima H; Hashimoto N J Neurosurg; 2017 Feb; 126(2):431-434. PubMed ID: 27177173 [TBL] [Abstract][Full Text] [Related]
18. Risks and benefits of combining denosumab and surgery in giant cell tumor of bone-a case series. Müller DA; Beltrami G; Scoccianti G; Campanacci DA; Franchi A; Capanna R World J Surg Oncol; 2016 Nov; 14(1):281. PubMed ID: 27809843 [TBL] [Abstract][Full Text] [Related]
19. [Clinical, radiologic and pathologic features of giant cell tumor of bone treated with denosumab]. Gong LH; Liu WF; Ding Y; Zhang W; Yang YK; Yu F; Wong GQ; Huang XY; Niu XH Zhonghua Bing Li Xue Za Zhi; 2018 Jun; 47(6):449-454. PubMed ID: 29886590 [No Abstract] [Full Text] [Related]
20. Denosumab, a Potential Alternative to the Surgical Treatment of Distal Radius Giant Cell Tumor of Bone: Case Report. Park MJ; Ganjoo KN; Ladd AL J Hand Surg Am; 2015 Aug; 40(8):1620-4. PubMed ID: 25935517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]